1
|
Verma S, Vats A, Ahuja V, Vats K, Khurana S, Vats Y, Gourie-Devi M, Wajid S, Ganguly NK, Chakraborti P, Taneja V. Functional consequences of familial ALS-associated SOD1 L84F in neuronal and muscle cells. FASEB J 2024; 38:e23461. [PMID: 38317639 DOI: 10.1096/fj.202301979r] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2023] [Revised: 01/10/2024] [Accepted: 01/18/2024] [Indexed: 02/07/2024]
Abstract
Amyotrophic lateral sclerosis is a fatal neurodegenerative disorder characterized by progressive skeletal muscle denervation and loss of motor neurons that results in muscle atrophy and eventual death due to respiratory failure. Previously, we identified a novel SOD1L84F variation in a familial ALS case. In this study, we examined the functional consequences of SOD1L84F overexpression in the mouse motor neuron cell line (NSC-34). The cells expressing SOD1L84F showed increased oxidative stress and increased cell death. Interestingly, SOD1L84F destabilized the native dimer and formed high molecular weight SDS-resistant protein aggregates. Furthermore, SOD1L84F also decreased the percentage of differentiated cells and significantly reduced neurite length. A plethora of evidence suggested active involvement of skeletal muscle in disease initiation and progression. We observed differential processing of the mutant SOD1 and perturbations of cellular machinery in NSC-34 and muscle cell line C2C12. Unlike neuronal cells, mutant protein failed to accumulate in muscle cells probably due to the activated autophagy, as evidenced by increased LC3-II and reduced p62. Further, SOD1L84F altered mitochondrial dynamics only in NSC-34. In addition, microarray analysis also revealed huge variations in differentially expressed genes between NSC-34 and C2C12. Interestingly, SOD1L84F hampered the endogenous FUS autoregulatory mechanism in NSC-34 by downregulating retention of introns 6 and 7 resulting in a two-fold upregulation of FUS. No such changes were observed in C2C12. Our findings strongly suggest the differential processing and response towards the mutant SOD1 in neuronal and muscle cell lines.
Collapse
Affiliation(s)
- Sagar Verma
- Department of Biotechnology and Research, Sir Ganga Ram Hospital, Delhi, India
- Department of Biotechnology, Jamia Hamdard, Delhi, India
| | - Abhishek Vats
- Department of Biotechnology and Research, Sir Ganga Ram Hospital, Delhi, India
- Department of Biotechnology, Jamia Hamdard, Delhi, India
- Department of Ophthalmology, Wilmer Eye Institute, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
| | - Vanshika Ahuja
- Department of Biotechnology and Research, Sir Ganga Ram Hospital, Delhi, India
| | - Kavita Vats
- Department of Dermatology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Shiffali Khurana
- Department of Biotechnology and Research, Sir Ganga Ram Hospital, Delhi, India
| | - Yuvraj Vats
- Department of Biotechnology and Research, Sir Ganga Ram Hospital, Delhi, India
| | | | - Saima Wajid
- Department of Biotechnology, Jamia Hamdard, Delhi, India
| | | | - Pradip Chakraborti
- Department of Biotechnology, Jamia Hamdard, Delhi, India
- Department of Biotechnology, Panjab University, Chandigarh, India
| | - Vibha Taneja
- Department of Biotechnology and Research, Sir Ganga Ram Hospital, Delhi, India
| |
Collapse
|
2
|
Verma S, Vats A, Devi MG, Khurana S, Ganguly NK, Chakraborti P, Taneja V. Differential regulation of L84F SOD1 in motor neurons and skeletal muscles: an insight into ALS pathology. FASEB J 2022. [DOI: 10.1096/fasebj.2022.36.s1.l7609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Sagar Verma
- BiotechnologyJamia HamdardNew Delhi
- ResearchSir Ganga Ram HospitalNew Delhi
| | | | | | | | | | | | | |
Collapse
|
3
|
Verma S, Khurana S, Vats A, Sahu B, Ganguly NK, Chakraborti P, Gourie-Devi M, Taneja V. Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis. Mol Neurobiol 2022; 59:1502-1527. [PMID: 34997540 DOI: 10.1007/s12035-021-02658-6] [Citation(s) in RCA: 27] [Impact Index Per Article: 13.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2021] [Accepted: 11/18/2021] [Indexed: 12/11/2022]
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurological disorder characterized by progressive degeneration of motor neurons leading to skeletal muscle denervation. Earlier studies have shown that motor neuron degeneration begins in motor cortex and descends to the neuromuscular junction (NMJ) in a dying forward fashion. However, accumulating evidences support that ALS is a distal axonopathy where early pathological changes occur at the NMJ, prior to onset of clinical symptoms and propagates towards the motor neuron cell body supporting "dying back" hypothesis. Despite several evidences, series of events triggering NMJ disassembly in ALS are still obscure. Neuromuscular junction is a specialized tripartite chemical synapse which involves a well-coordinated communication among the presynaptic motor neuron, postsynaptic skeletal muscle, and terminal Schwann cells. This review provides comprehensive insight into the role of NMJ in ALS pathogenesis. We have emphasized the molecular alterations in cellular components of NMJ leading to loss of effective neuromuscular transmission in ALS. Further, we provide a preview into research involved in exploring NMJ as potential target for designing effective therapies for ALS.
Collapse
Affiliation(s)
- Sagar Verma
- Department of Research, Sir Ganga Ram Hospital, Delhi, India.,Department of Biotechnology, Jamia Hamdard, Delhi, India
| | - Shiffali Khurana
- Department of Research, Sir Ganga Ram Hospital, Delhi, India.,Department of Biomedical Science, Bhaskaracharya College of Applied Sciences, University of Delhi, Delhi, India
| | - Abhishek Vats
- Department of Ophthalmology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
| | - Bandana Sahu
- Department of Research, Sir Ganga Ram Hospital, Delhi, India
| | | | | | | | - Vibha Taneja
- Department of Research, Sir Ganga Ram Hospital, Delhi, India.
| |
Collapse
|
4
|
Das P, Bandyopadhyay S, Mohammed R, Mallik C, Eyre M, Chakraborti P. Outcome Of Elective Nodal Radiation In Elderly Patients With High Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.582] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
5
|
Verma S, Vats A, Gourie-Devi M, Khurana S, Ganguly NK, Chakraborti P, Taneja V. Modelling a Novel Superoxide Dismutase 1 Mutation in Motor Neurons: An Insight into Molecular Pathomechanism of Amyotrophic Lateral Sclerosis. FASEB J 2020. [DOI: 10.1096/fasebj.2020.34.s1.04997] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
6
|
Sydes MR, Spears MR, Mason MD, Clarke NW, Dearnaley DP, de Bono JS, Attard G, Chowdhury S, Cross W, Gillessen S, Malik ZI, Jones R, Parker CC, Ritchie AWS, Russell JM, Millman R, Matheson D, Amos C, Gilson C, Birtle A, Brock S, Capaldi L, Chakraborti P, Choudhury A, Evans L, Ford D, Gale J, Gibbs S, Gilbert DC, Hughes R, McLaren D, Lester JF, Nikapota A, O'Sullivan J, Parikh O, Peedell C, Protheroe A, Rudman SM, Shaffer R, Sheehan D, Simms M, Srihari N, Strebel R, Sundar S, Tolan S, Tsang D, Varughese M, Wagstaff J, Parmar MKB, James ND. Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol. Ann Oncol 2018; 29:1235-1248. [PMID: 29529169 PMCID: PMC5961425 DOI: 10.1093/annonc/mdy072] [Citation(s) in RCA: 175] [Impact Index Per Article: 29.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Background Adding abiraterone acetate with prednisolone (AAP) or docetaxel with prednisolone (DocP) to standard-of-care (SOC) each improved survival in systemic therapy for advanced or metastatic prostate cancer: evaluation of drug efficacy: a multi-arm multi-stage platform randomised controlled protocol recruiting patients with high-risk locally advanced or metastatic PCa starting long-term androgen deprivation therapy (ADT). The protocol provides the only direct, randomised comparative data of SOC + AAP versus SOC + DocP. Method Recruitment to SOC + DocP and SOC + AAP overlapped November 2011 to March 2013. SOC was long-term ADT or, for most non-metastatic cases, ADT for ≥2 years and RT to the primary tumour. Stratified randomisation allocated pts 2 : 1 : 2 to SOC; SOC + docetaxel 75 mg/m2 3-weekly×6 + prednisolone 10 mg daily; or SOC + abiraterone acetate 1000 mg + prednisolone 5 mg daily. AAP duration depended on stage and intent to give radical RT. The primary outcome measure was death from any cause. Analyses used Cox proportional hazards and flexible parametric models, adjusted for stratification factors. This was not a formally powered comparison. A hazard ratio (HR) <1 favours SOC + AAP, and HR > 1 favours SOC + DocP. Results A total of 566 consenting patients were contemporaneously randomised: 189 SOC + DocP and 377 SOC + AAP. The patients, balanced by allocated treatment were: 342 (60%) M1; 429 (76%) Gleason 8-10; 449 (79%) WHO performance status 0; median age 66 years and median PSA 56 ng/ml. With median follow-up 4 years, 149 deaths were reported. For overall survival, HR = 1.16 (95% CI 0.82-1.65); failure-free survival HR = 0.51 (95% CI 0.39-0.67); progression-free survival HR = 0.65 (95% CI 0.48-0.88); metastasis-free survival HR = 0.77 (95% CI 0.57-1.03); prostate cancer-specific survival HR = 1.02 (0.70-1.49); and symptomatic skeletal events HR = 0.83 (95% CI 0.55-1.25). In the safety population, the proportion reporting ≥1 grade 3, 4 or 5 adverse events ever was 36%, 13% and 1% SOC + DocP, and 40%, 7% and 1% SOC + AAP; prevalence 11% at 1 and 2 years on both arms. Relapse treatment patterns varied by arm. Conclusions This direct, randomised comparative analysis of two new treatment standards for hormone-naïve prostate cancer showed no evidence of a difference in overall or prostate cancer-specific survival, nor in other important outcomes such as symptomatic skeletal events. Worst toxicity grade over entire time on trial was similar but comprised different toxicities in line with the known properties of the drugs. Trial registration Clinicaltrials.gov: NCT00268476.
Collapse
Affiliation(s)
- M R Sydes
- MRC Clinical Trials Unit at UCL, London.
| | | | | | - N W Clarke
- Christie and Royal Salford Hospital, Manchester
| | | | | | - G Attard
- UCL Cancer Institute, University College London, London
| | - S Chowdhury
- Guy's & St Thomas NHS, Foundation Trust, London
| | - W Cross
- St James University Hospital, Leeds, UK
| | - S Gillessen
- Division of Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen; University of Bern, Bern; Swiss Group for Cancer Clinical Research (SAKK), Bern, Switzerland
| | - Z I Malik
- The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool
| | - R Jones
- Institute of Cancer Sciences, University of Glasgow, Glasgow; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow
| | - C C Parker
- Institute of Cancer Research, Sutton; Royal Marsden Hospital, Sutton
| | | | - J M Russell
- Institute of Cancer Sciences, University of Glasgow, Glasgow; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow
| | - R Millman
- MRC Clinical Trials Unit at UCL, London
| | - D Matheson
- Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton
| | - C Amos
- MRC Clinical Trials Unit at UCL, London
| | - C Gilson
- MRC Clinical Trials Unit at UCL, London
| | - A Birtle
- Rosemere Cancer Centre, Royal Preston Hospital, Preston
| | - S Brock
- Dorset Cancer Centre, Poole Hospital, Poole
| | - L Capaldi
- Worcestershire Acute Hospitals NHS Trust, Worcester
| | | | - A Choudhury
- Division of Cancer Sciences, University of Manchester, Manchester; Manchester Academic Health Science Centre, Manchester; Christie Hospital NHS Foundation Trust, Manchester
| | - L Evans
- Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield
| | - D Ford
- City Hospital, Cancer Centre at Queen Elizabeth Hospital, Birmingham
| | - J Gale
- Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth
| | | | - D C Gilbert
- Sussex Cancer Centre, Royal Sussex County Hospital, Brighton
| | - R Hughes
- Mount Vernon Group, Mount Vernon Hospital, Middlesex
| | | | | | | | - J O'Sullivan
- Centre for Cancer Research and Cell Biology, Queens University Belfast, Belfast; Belfast City Hospital, Belfast
| | - O Parikh
- Lancashire Teaching Hospitals NHS Trust, Preston
| | - C Peedell
- Department of Oncology & Radiotherapy, South Tees NHS Trust, Middlesbrough
| | - A Protheroe
- Oxford University Hospitals NHS Foundation Trust
| | - S M Rudman
- Guy's & St Thomas NHS, Foundation Trust, London
| | - R Shaffer
- Department of Oncology, Royal Surrey County Hospital, Guildford
| | - D Sheehan
- Royal Devon and Exeter Hospital, Exeter
| | - M Simms
- Hull & East Yorkshire Hospitals NHS Trust, Hull
| | - N Srihari
- Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury, UK
| | - R Strebel
- Kantonsspital Graubünden, Chur; Swiss Group for Cancer Clinical Research (SAKK), Bern, Switzerland
| | - S Sundar
- Department of Oncology, Nottingham, University Hospitals NHS Trust, Nottingham
| | - S Tolan
- The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool
| | - D Tsang
- Southend Hospital, Southend-on-Sea
| | - M Varughese
- Musgrove Park Hospital, Taunton and Somerset NHS Foundation Trust
| | - J Wagstaff
- Swansea University College of Medicine, Swansea
| | | | - N D James
- Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, UK
| |
Collapse
|
7
|
Ganguly B, Mandal S, Dolai T, De R, Prasad P, Chakraborti P. 189 ALL MDS-SPECIFIC STRUCTURAL CHROMOSOMAL REARRANGEMENTS IN A SINGLE CASE. Leuk Res 2015. [DOI: 10.1016/s0145-2126(15)30190-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
8
|
Ravala S, Yadav G, Chakraborti P. Deciphering crucial threonines towards functionality of an essential eukaryotic‐type Ser/Thr kinase from
M. tuberculosis
(802.1). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.802.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
9
|
Lambert KV, Tanteles GA, Mills J, Murray R, Chakraborti P, Chan S, Cheung KL, Osman A, Peat I, Woodings P, Barwell J, Talbot C, Symonds P, Shokuhi S, Stotter AT. Abstract P4-11-17: Can We Specifiy the Minimum Breast Size at Which Therapeutic Mammoplasty Should Be Considered To Mitigate Radiotherapy Toxicity in Patients Undergoing Breast Conserving Surgery for Breast Cancer? Cancer Res 2010. [DOI: 10.1158/0008-5472.sabcs10-p4-11-17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background
For breast cancer patients undergoing breast conserving surgery, local complications after breast radiotherapy have in the past been shown to be proportional to breast size. Therapeutic mammoplasty is an option to extend the role of breast conserving surgery. In our units, it has been used in larger breasted women undergoing breast conserving surgery to reduce the risk of local radiotherapy complications.
Aim
The aim of this multicentre study was to determine, with modern radiotherapy dosing schedules, if it is possible to specify a minimum bra cup size at which therapeutic mammoplasty should be considered.
Methods
Recurrence free breast cancer patients (at least 3 years post conservative surgery and radiotherapy) were identified from three oncology follow up clinics in the United Kingdom.
50Gy in 25 fractions over 5 weeks prescribed to the 100% isodose at the ICRU reference point, on the central outline of the breast had been a typical dosing schedule. Radiotherapy effects were graded using the Late Effects of Normal Tissue-Subjective Objective Management Analytical (LENT-SOMA) score. A score of two or above was taken as representing that the particular toxicity variable was present. The relationship between radiotherapy toxicity variables was calculated using the Pearson correlation co-efficient.
Results
479 breast cancer patients were assessed. Increasing cup size correlated with oedema (Pearson correlation co-efficient r=0.30, p=<0.0001), induration (r=0.31, p=<0.0001), telangiectasia (r=0.24, p=<0.0001), breast retraction (r=0.15, p=0.002) and pain (r=0.10, p=0.030). 2.3% of patients with cup size AA/A exhibited fibrosis, 6.6% with cup size B or C, 11.8% cup size D and 25.5% with cup size DD and above. Conclusion
Local radiotherapy complications following breast conserving surgery for breast cancer remain proportional to breast size even with modern radiotherapy equipment and dosing schedules. This effect is most pronounced in women with a bra cup size D and above. For these women, therapeutic mammoplasty should be considered. Further work to identify the genetic determinants of normal-tissue radiation damage is underway to optimise the surgical decision.
Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr P4-11-17.
Collapse
Affiliation(s)
- KV Lambert
- University Hospitals Leicester, Leicestershire, United Kingdom; University of Leicester, Leicestershire, United Kingdom; University of Leicester, United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, Derbyshire, United Kingdom; Nottingham University Hospitals NHS Trust (City Hospital Campus), Nottingham, Nottinghamshire, United Kingdom
| | - GA Tanteles
- University Hospitals Leicester, Leicestershire, United Kingdom; University of Leicester, Leicestershire, United Kingdom; University of Leicester, United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, Derbyshire, United Kingdom; Nottingham University Hospitals NHS Trust (City Hospital Campus), Nottingham, Nottinghamshire, United Kingdom
| | - J Mills
- University Hospitals Leicester, Leicestershire, United Kingdom; University of Leicester, Leicestershire, United Kingdom; University of Leicester, United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, Derbyshire, United Kingdom; Nottingham University Hospitals NHS Trust (City Hospital Campus), Nottingham, Nottinghamshire, United Kingdom
| | - R Murray
- University Hospitals Leicester, Leicestershire, United Kingdom; University of Leicester, Leicestershire, United Kingdom; University of Leicester, United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, Derbyshire, United Kingdom; Nottingham University Hospitals NHS Trust (City Hospital Campus), Nottingham, Nottinghamshire, United Kingdom
| | - P Chakraborti
- University Hospitals Leicester, Leicestershire, United Kingdom; University of Leicester, Leicestershire, United Kingdom; University of Leicester, United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, Derbyshire, United Kingdom; Nottingham University Hospitals NHS Trust (City Hospital Campus), Nottingham, Nottinghamshire, United Kingdom
| | - S Chan
- University Hospitals Leicester, Leicestershire, United Kingdom; University of Leicester, Leicestershire, United Kingdom; University of Leicester, United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, Derbyshire, United Kingdom; Nottingham University Hospitals NHS Trust (City Hospital Campus), Nottingham, Nottinghamshire, United Kingdom
| | - KL Cheung
- University Hospitals Leicester, Leicestershire, United Kingdom; University of Leicester, Leicestershire, United Kingdom; University of Leicester, United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, Derbyshire, United Kingdom; Nottingham University Hospitals NHS Trust (City Hospital Campus), Nottingham, Nottinghamshire, United Kingdom
| | - A Osman
- University Hospitals Leicester, Leicestershire, United Kingdom; University of Leicester, Leicestershire, United Kingdom; University of Leicester, United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, Derbyshire, United Kingdom; Nottingham University Hospitals NHS Trust (City Hospital Campus), Nottingham, Nottinghamshire, United Kingdom
| | - I Peat
- University Hospitals Leicester, Leicestershire, United Kingdom; University of Leicester, Leicestershire, United Kingdom; University of Leicester, United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, Derbyshire, United Kingdom; Nottingham University Hospitals NHS Trust (City Hospital Campus), Nottingham, Nottinghamshire, United Kingdom
| | - P Woodings
- University Hospitals Leicester, Leicestershire, United Kingdom; University of Leicester, Leicestershire, United Kingdom; University of Leicester, United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, Derbyshire, United Kingdom; Nottingham University Hospitals NHS Trust (City Hospital Campus), Nottingham, Nottinghamshire, United Kingdom
| | - J Barwell
- University Hospitals Leicester, Leicestershire, United Kingdom; University of Leicester, Leicestershire, United Kingdom; University of Leicester, United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, Derbyshire, United Kingdom; Nottingham University Hospitals NHS Trust (City Hospital Campus), Nottingham, Nottinghamshire, United Kingdom
| | - C Talbot
- University Hospitals Leicester, Leicestershire, United Kingdom; University of Leicester, Leicestershire, United Kingdom; University of Leicester, United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, Derbyshire, United Kingdom; Nottingham University Hospitals NHS Trust (City Hospital Campus), Nottingham, Nottinghamshire, United Kingdom
| | - P Symonds
- University Hospitals Leicester, Leicestershire, United Kingdom; University of Leicester, Leicestershire, United Kingdom; University of Leicester, United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, Derbyshire, United Kingdom; Nottingham University Hospitals NHS Trust (City Hospital Campus), Nottingham, Nottinghamshire, United Kingdom
| | - S Shokuhi
- University Hospitals Leicester, Leicestershire, United Kingdom; University of Leicester, Leicestershire, United Kingdom; University of Leicester, United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, Derbyshire, United Kingdom; Nottingham University Hospitals NHS Trust (City Hospital Campus), Nottingham, Nottinghamshire, United Kingdom
| | - AT. Stotter
- University Hospitals Leicester, Leicestershire, United Kingdom; University of Leicester, Leicestershire, United Kingdom; University of Leicester, United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, Derbyshire, United Kingdom; Nottingham University Hospitals NHS Trust (City Hospital Campus), Nottingham, Nottinghamshire, United Kingdom
| |
Collapse
|
10
|
Di Spigna N, Chakraborti P, Winick D, Yang P, Ghosh T, Franzon P. The integration of novel EAP-based Braille cells for use in a refreshable tactile display. ACTA ACUST UNITED AC 2010. [DOI: 10.1117/12.847666] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
11
|
Mulla MG, Ananthkrishnan G, Mirza MS, Bungay P, Puri S, Chakraborti P. Renal artery stenosis after radiotherapy for stage I seminoma, a case report. Clin Oncol (R Coll Radiol) 2007; 19:209. [PMID: 17359909 DOI: 10.1016/j.clon.2007.01.114] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2007] [Accepted: 01/15/2007] [Indexed: 11/30/2022]
|
12
|
Chatterjee U, Mondal G, Chakraborti P, Patra HK, Chatterjee BP. Changes in the Allergenicity during Different Preparations of Pomfret, Hilsa, Bhetki and Mackerel Fish as Illustrated by Enzyme-Linked Immunosorbent Assay and Immunoblotting. Int Arch Allergy Immunol 2006; 141:1-10. [PMID: 16804323 DOI: 10.1159/000094176] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2005] [Accepted: 02/21/2006] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Although the identification and characterization of several fish allergens have already been reported, there is almost no data on Indian fish allergens and the effect of thermal processing on their allergenicity. This study aimed at the evaluation of the changes in the level of allergenicity of 4 highly consumed Indian fishes, i.e. pomfret, hilsa, bhetki and mackerel, that occurred after boiling and frying. METHODS In this study 110 patients with fish hypersensitivity as evidenced by clinical history and symptoms were recruited based on their positive skin prick test results. The raw, boiled and fried muscle extracts of the 4 fishes were prepared, and each extract was tested by ELISA and immunoblotting with patients' sera. RESULTS ELISA and immunoblotting studies demonstrated that the raw muscle extracts of pomfret, hilsa, bhetki and mackerel were allergenic. While the allergenicity of boiled and fried extracts of pomfret and hilsa was considerably reduced, maximum allergenicity of bhetki was demonstrated in the fried extract. The degree of allergenicity of bhetki was demonstrated in the order fried>boiled>raw while that of mackerel followed the order raw>boiled approximately fried. CONCLUSION The specific IgE-binding activity and immunoblot profile clearly showed that pomfret and hilsa fish allergens are heat-labile, while allergens of bhetki and mackerel maintained strong reactivity even after thermal treatment.
Collapse
Affiliation(s)
- U Chatterjee
- Department of Biological Chemistry, Indian Association for the Cultivation of Science, Jadavpur, Kolkata, India
| | | | | | | | | |
Collapse
|
13
|
Abstract
Thyroid hormone is known to play a pivotal role in the regulation of prepuberal rat testes development and function with specific influence on the differentiation of Sertoli cells, the only cell type that expresses thyroid hormone receptors in testes. To explore in vivo effects of thyroid hormone on testes development and the regulation of testicular gene expression, the hyper- and hypothyroid rat models were established by T3 injection to pups (ip 100 microg/kg bw) and by oral administration of 6-N-propyl-2-thiouracil (PTU) to the lactating mother from days 1 to 21 post-delivery. Half of the rats from each group were sacrificed at 21 days of age, and the other half were allowed to recover with discontinued treatments from day 22 to day 50. At 21 days of age, a significantly elevated serum T3 level was observed in hyperthyroid rats (179.5 ng/dl) vs controls (97.5 ng/dl), and in hypothyroid rats a significantly lower level of T3 was detected (26.1 ng/dl). However, serum T4 concentration was significantly lower in both hyper- (0.105 microg/dl) and hypothyroid (0.058 microg/dl) rats compared to the controls (2.48 microg/dl). In recovered rats in which the serum T3 and T4 were restored to normal, the serum T levels remained remarkably lower in both hyper- and hypothyroid rats. The significantly decreased body and testes weights observed in both hyper- and hypothyroid rats at 21 days of age were not restored by the time they were 50 days old. Histological analyses of testes of 21-day-old hypothyroid rats revealed smaller-sized seminiferous tubules, incomplete lumen formation and delayed germ cell differentiation and in hyperthyroid rats an increased number of early stage spermatocytes was found. Testicular mRNA levels of follicle-stimulating hormone receptor (FSH-R), luteinizing hormone receptor (LH-R) and androgen binding protein (ABP) were studied by Northern blot hybridization. At 21 days of age data showed that FSH-R mRNA levels were significantly higher in both hyper- and hypothyroid rat testes compared to controls, but no differences were detected in recovered 50-day-old rats. Significantly decreased ABP mRNA levels were detected only in hypothyroid rat testes compared to those in both the hyperthyroid and control groups at 21 days of age, but no significant change was observed in recovered 50-day-old rats. To further evaluate the effect of thyroid hormone on the Leydig cell function, the 2.3/2.6 kb specific LH-R hybridization bands were detected with rat LH-R cRNA probe. Significant suppression of LH-R mRNA levels was only observed in the hypothyroid rat testes at 50 days of age. The testicular thyroid hormone receptors (TRs) and the regulation of TR by thyroid hormone were investigated using semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) assays. Both TRalpha and TRbeta mRNAs were identified in the testes from 21- and/or 50-day-old rats. TRalpha mRNA levels were significantly increased in hypothyroid rat testes and were suppressed in hyperthyroid rats at 21 days of age and no changes of TRalpha mRNA were found in recovered animals. Our in vivo data strongly suggest that the thyroid hormone directly affects the development of prepuberal testes and the regulation of FSH-R and ABP gene expression in Sertoli cells, as well as the LH-R mRNA levels in Leydig cells, which may lead to further modulating the effect of gonadotropins on testes function.
Collapse
Affiliation(s)
- J N Rao
- Department of Surgery, University of Maryland and Veterans Affairs Medical Center, Baltimore, Maryland, USA
| | | | | | | |
Collapse
|
14
|
Abstract
The effects of prolactin (PRL) from both mammalian and piscine sources on plasma calcium levels in common carp, Cyprinus carpio, were investigated. Injections of ovine prolactin (oPRL) or homologous fish pituitary extract or partially purified prolactin of murrel, Channa punctatus pituitary (mPRL), caused significant increases in total and ultrafiltrable plasma calcium. Larger hypercalcemic responses were observed in fish kept in high-calcium fresh water and normal tap water than in fish in low-calcium fresh water. Injections of oPRL caused dose-dependent increases in plasma calcium level. The highest dose (1 mg/kg body wt) of oPRL had a reduced hypercalcemic effect. Administration of EGTA (200 microM/kg body wt) reduced the stimulatory effects of daily injections of oPRL or mPRL on plasma calcium in freshwater common carp under laboratory conditions. These results indicate that PRL may be involved in regulating plasma calcium levels in fish.
Collapse
Affiliation(s)
- P Chakraborti
- Department of Zoology, University of Kalyani, West Bengal, India
| | | |
Collapse
|
15
|
Mukherjee D, Kumar V, Chakraborti P. Effect of mercuric chloride and cadmium chloride on gonadal function and its regulation in sexually mature common carp Cyprinus carpio. Biomed Environ Sci 1994; 7:13-24. [PMID: 8024715] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
Gonadal function in fish, Cyprinus carpio was significantly affected by sublethal doses of mercuric chloride (HgCl2) and cadmium chloride (CdCl2) in chronic (45 days) exposure. Parameters investigated were nonesterified (NE) and esterified (E) cholesterol of ovary, liver and serum and ovarian 3 beta-Hydroxysteroid and 17 beta-Hydroxysteroid dehydrogenase enzyme activity and serum and pituitary gonadotropin (GtH) levels. Both the pollutants were able to reduce the hypothalamic extract (HE) or gonadotropin releasing hormone (GnRH) induced pituitary GtH release in vitro. Short term (96h) exposure of the fish to the pollutants had no significant effect on the gonadal function. In addition to the deleterious effect of pollutants on the gonadal steroidogenesis and pituitary gonadotropin release, using [4-14C] cholesterol as a tracer it was found that for 45 days exposure, HgCl2 had an adverse effect on the transport of cholesterol from circulation to ovary.
Collapse
Affiliation(s)
- D Mukherjee
- Department of Zoology, University of Kalyani, India
| | | | | |
Collapse
|
16
|
Chang TM, Chakraborti P, Chang CH. The cyanogen bromide fragment I of asialoorosomucoid is transported more efficiently than asialoorosomucoid in rat hepatocytes. Biochim Biophys Acta 1989; 1010:166-76. [PMID: 2912500 DOI: 10.1016/0167-4889(89)90157-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Cultured rat hepatocytes internalized and degraded 125I-labeled asialoorosomucoid (125I-ASOR) through asialoglycoprotein receptor at rates about half that of its cyanogen bromide fragment I (125I-ASCNBr-I). Reduction and carboxymethylation of the fragment resulted in decreased rates of internalization and degradation which were still greater than those of 125I-ASOR. In the presence of 5 microM colchicine, degradation of all three ligands was inhibited. However, the intracellular level of 125I-ASOR at steady state remained unchanged, while those of the fragments increased continuously. Study of the binding of these ligands to hepatocytes at 4 degrees C indicated that there was no significant difference in binding parameters between ASOR, ASCNBr-I and RC-ASCNBr-I (reduced and carboxymet ASCNBr-I). Studies of the fate of these ligands preloaded in the cell at 37 degrees C indicated that a higher fraction of the internalized ASOR than of the fragments was released by diacytosis. In contrast to ASOR, diacytosis of the fragments was not enhanced by colchicine. Studies of the distribution of intracellular ligands by Percoll density gradient centrifugation indicated that they were internalized initially into two early endosomal compartments of d = 1.037 g/ml and d = 1.045 g/ml. In the presence of colchicine, accumulation of the ligands in a third endosomal compartment of d = 1.08-1.095 g/ml was revealed, while in the presence of leupeptin accumulation of the ligands in lysosomes was observed. The results of a kinetic analysis indicated that both cyanogen bromide fragments were transported to all these compartments more rapidly than was ASOR. It appears that they are internalized and degraded more rapidly than ASOR due to a more efficient sorting of the internalized ligand into the pathway of lysosomal degradation.
Collapse
Affiliation(s)
- T M Chang
- Department of Medicine, Genesee Hospital, Rochester, NY 14607
| | | | | |
Collapse
|
17
|
Abstract
High affinity, low capacity 3,5,3'-triiodo-L-thyronine (T3) specific binding was detected in the pure nuclei preparation from ovarian tissue of freshwater perch by employing an in vitro thyroid hormone binding assay. Under standardized assay conditions of pH 7.0 at 30 degrees and 1 hr incubation time, the binding in the ovarian nuclei was saturable with a Kd 9.1 X 10(-9) M. For comparison, a Scatchard analysis of T3 binding to perch hepatic nuclei was done and a higher Kd value (16.89 X 10(-9) M) with twofold increase in maximum binding capacity (MBC 8.882 and 4.312 pmol/mg DNA in liver and ovary, respectively) was observed. Competitive inhibition studies showed ovarian T3 binding to be hormone specific with relative binding affinities comparable to T3 binding in other systems. T3 binding to the nuclear preparation from tail kidney and brain tissue of perch was considerably lower in comparison to liver and ovarian nuclei. Functional relevance of T3 binding to perch ovarian nuclei was tested by incubating ovarian tissue in vitro with T3. T3 significantly (P less than 0.001) increased protein synthesis in comparison to control.
Collapse
|
18
|
Chakraborti P, Maitra G, Bhattacharya S. Effect of gonadotropins and gonadal hormones on female fish thyroid peroxidase activity. Indian J Biochem Biophys 1984; 21:85-8. [PMID: 6490080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
19
|
Abstract
Plasma thyroxine (T4) of a freshwater female perch Anabas testudineus (Bloch) has been measured by specific radioimmunoassay (RIA). Monitoring of plasma T4 throughout the year showed that July to early September (spawning stage) had the highest T4 and late September to January (postspawning stage) had the lowest T4. The plasma T4 cycle was coincident with the ovarian cycle. Treatment of intact perch with salmon gonadotropin (SG-G100) or ovine LH (500 ng/100 g body wt) markedly enhanced plasma T4 levels. Ovine FSH was without any effect. Ovarian steroids, estrone and 17 beta-estradiol (100 ng/100 g body wt), also significantly augmented T4 level whereas estriol or progesterone had no such effect. There was a striking fall of plasma T4 in ovariectomized fish. The drop of T4 due to ovariectomy could not be reversed by SG-G100 but administration of estrone or 17 beta-estradiol to ovariectomized fish effectively reversed the drop of plasma T4 level. These findings suggest that gonadotropin's stimulatory effect on perch thyroid is mediated via the release of ovarian steroids.
Collapse
|
20
|
Jamaluddin M, Chakraborti P, Bhattacharya S. Hormonal regulation of plasma thyroxine level in a murrel Channa punctatus (Bloch). Indian J Exp Biol 1983; 21:386-9. [PMID: 6667995] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
|
21
|
Chakraborti P, Rakshit DK, Bhattacharya S. Influence of season, gonadotropins, and gonadal hormones on the thyroid activity of freshwater perch, Anabas testudineus (Bloch). CAN J ZOOL 1983. [DOI: 10.1139/z83-047] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Perch thyroid activity fluctuated in different phases of the reproductive cycle, being highest at spawning and lowest at postspawning. Treatment of intact perch with salmon gonadotropin (SG-G100) or ovine luteinizing hormone (LH) (1 μg/100 g body weight) for 15 days markedly enhanced thyroid activity. The extent of stimulation was greater with SG-G 100 than with LH. Follicle-stimulating hormone (FSH) had no effect. Ovarian steroids, 17β-estradiol and estrone (100 ng/100 g body weight), also significantly augmented thyroid activity. There was a striking reduction of thyroid activity as a result of ovariectomy, a decrease that could not be improved by SG-G100; however, estrone or 17β-estradiol supplementation resulted in a significant increase of thyroid activity in comparison with ovariectomized controls. These findings suggest that gonadotropin mediated its stimulatory effect on perch thyroid activity via the release of ovarian steroids.
Collapse
|
22
|
Chakraborti P, Bhattacharya S. Influence of gonadotropins and gonadal hormones on climbing perch thyroid nucleic acids. Endokrinologie 1982; 80:213-219. [PMID: 6186473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
Climbing perch thyroidal RNA content fluctuated in different phases of the reproductive cycle, highest at spawning (36.08 +/- 3.69 micrograms/mg tissue) and lowest at postspawning (6.88 +/- 0.76 microgram/mg tissue) whereas DNA remained unaltered. Treatment of intact perch with salmon gonadotropin (SG-G100) or ovine LH for 15 days significantly stimulated thyroidal RNA content. Stimulatory effect of SG-G100 was greater (p less than 0.001) than LH (p less than 0.005). FSH had no such effect. Gonadotropin (GtH) treatment could not alter thyroidal DNA. Ovarian steroids, 17 beta-estradiol (E2) and estrone (E1) remarkably elicited RNA content. Ovariectomy of perch caused striking depletion of RNA. Administration of GtH to ovariectomized perch had no effect on thyroid RNA but E1 and E2 supplementation resulted in significant stimulation in comparison to ovariectomized control. Findings indicate that GtH mediated its stimulatory effect on perch thyroidal RNA via the release of ovarian steroids.
Collapse
|
23
|
Chakraborti P, Bhattacharya S. Bovine TSH-stimulation of fish thyroid peroxidase activity and role of thyroxine thereon. Experientia 1978; 34:136-7. [PMID: 620727 DOI: 10.1007/bf01921948] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
bTSH augmented the fish thyroid peroxidase activity in a dose-response manner. Thyroxine could not modulate the effect of exogenous bTSH, but it decreased the peroxidase activity in a control system when administered alone. The data therefore suggest similar negative feedback control system for TSH-regulation as operative in the case of mammals.
Collapse
|